Minimizing opioid consumption by eliminating patient-controlled analgesia after penile inversion vaginoplasty with enhanced recovery after surgery (ERAS) protocol.
Minimizing opioid consumption by eliminating patient-controlled analgesia after penile inversion vaginoplasty with enhanced recovery after surgery (ERAS) protocol.
- 2022
BACKGROUND: Genital-based gender affirmation surgery is a physically demanding procedure requiring extensive postoperative pain management. However, perioperative opioid use for these procedures is relatively understudied. CONCLUSION: Minimizing postoperative opioid consumption after PIV will benefit patients and their sustained well-being. Copyright (c) 2021 American Society of Andrology and European Academy of Andrology. DISCUSSION: In combination with an ERAS non-narcotic pain control protocol, it may be possible to reduce opioid use by more than 50% and shorten length of postoperative hospital stay among patients by implementing NCA pain management protocols. METHODS: All patients undergoing PIV with ERAS protocols by a single provider from December 2018 to November 2020 were retrospectively reviewed. Patient demographics, comorbid conditions, pain scores, length of stay (LOS), and opioid usage during their hospitalization were collected. Postoperative opioid use and pain scores were compared between PCA and NCA patient cohorts. OBJECTIVES: This study analyzes whether intravenous patient-controlled analgesia (PCA) enhances pain control after penile inversion vaginoplasty (PIV) in the setting of enhanced recovery after surgery (ERAS) protocols, and whether non-PCA (NCA)-based regimens could reduce postoperative opioid use. RESULTS: A total of 61 patients were included. 30 patients received intravenous PCA postoperatively, and 31 patients used NCA-based narcotic pain control. All patients underwent ERAS protocol perioperatively. Average patient age was 34.5 years (SD 11.9) in the PCA cohort and 37.6 years (SD 11.9) in the NCA cohort (p = 0.242). Average total postoperative opioid use during hospital stay was reduced by 53.7% in the NCA cohort, with an average use of 501.6 morphine milligram equivalents (MME) (SD 410.3) among PCA patients and an average use of 232.0 MME (SD 216.5) among NCA patients (p = 0.003). Daily average pain scores for postoperative days 1 to 6 did not differ between the PCA and NCA patient groups (p > 0.05). Average hospital LOS was shorter among NCA patients, 6.2 days (SD 1.0) versus 7.3 days (SD 1.4), respectively, (p < 0.001).
English
2047-2919
*Analgesics, Opioid/tu [Therapeutic Use]
*Enhanced Recovery After Surgery
*Pain Management/mt [Methods]
*Pain, Postoperative/dt [Drug Therapy]
*Sex Reassignment Surgery/rh [Rehabilitation]
Adult
Female
Humans
Length of Stay
Male
Pain Measurement
Retrospective Studies
Sex Reassignment Surgery/ae [Adverse Effects]
Treatment Outcome
MedStar Washington Hospital Center
Surgery/Plastic Surgery
Journal Article
BACKGROUND: Genital-based gender affirmation surgery is a physically demanding procedure requiring extensive postoperative pain management. However, perioperative opioid use for these procedures is relatively understudied. CONCLUSION: Minimizing postoperative opioid consumption after PIV will benefit patients and their sustained well-being. Copyright (c) 2021 American Society of Andrology and European Academy of Andrology. DISCUSSION: In combination with an ERAS non-narcotic pain control protocol, it may be possible to reduce opioid use by more than 50% and shorten length of postoperative hospital stay among patients by implementing NCA pain management protocols. METHODS: All patients undergoing PIV with ERAS protocols by a single provider from December 2018 to November 2020 were retrospectively reviewed. Patient demographics, comorbid conditions, pain scores, length of stay (LOS), and opioid usage during their hospitalization were collected. Postoperative opioid use and pain scores were compared between PCA and NCA patient cohorts. OBJECTIVES: This study analyzes whether intravenous patient-controlled analgesia (PCA) enhances pain control after penile inversion vaginoplasty (PIV) in the setting of enhanced recovery after surgery (ERAS) protocols, and whether non-PCA (NCA)-based regimens could reduce postoperative opioid use. RESULTS: A total of 61 patients were included. 30 patients received intravenous PCA postoperatively, and 31 patients used NCA-based narcotic pain control. All patients underwent ERAS protocol perioperatively. Average patient age was 34.5 years (SD 11.9) in the PCA cohort and 37.6 years (SD 11.9) in the NCA cohort (p = 0.242). Average total postoperative opioid use during hospital stay was reduced by 53.7% in the NCA cohort, with an average use of 501.6 morphine milligram equivalents (MME) (SD 410.3) among PCA patients and an average use of 232.0 MME (SD 216.5) among NCA patients (p = 0.003). Daily average pain scores for postoperative days 1 to 6 did not differ between the PCA and NCA patient groups (p > 0.05). Average hospital LOS was shorter among NCA patients, 6.2 days (SD 1.0) versus 7.3 days (SD 1.4), respectively, (p < 0.001).
English
2047-2919
*Analgesics, Opioid/tu [Therapeutic Use]
*Enhanced Recovery After Surgery
*Pain Management/mt [Methods]
*Pain, Postoperative/dt [Drug Therapy]
*Sex Reassignment Surgery/rh [Rehabilitation]
Adult
Female
Humans
Length of Stay
Male
Pain Measurement
Retrospective Studies
Sex Reassignment Surgery/ae [Adverse Effects]
Treatment Outcome
MedStar Washington Hospital Center
Surgery/Plastic Surgery
Journal Article